The AHA Dec. 7 sent a letter supporting the Support for Patients and Communities Reauthorization Act (H.R. 4531), bipartisan legislation that would reauthorize key SUPPORT Act programs for patients with substance use disorder and permanently extend required Medicaid coverage for medication-assisted treatments. As urged by the AHA in June, the bill also would permanently extend the option for state Medicaid programs to receive federal matching payments for substance use disorder treatment provided in certain Institutions for Mental Disease for up to 30 days over a 12-month period. 
 
"For our members, this flexibility allows them to ensure patients receive the specific care they need," AHA said in a letter to the bill’s sponsors, Reps. Brett Guthrie, R-Ky., and Ann Kuster, D-N.H. "Both provisions take important steps forward in increasing access to SUD treatment services and reducing the stigma associated with seeking out the help that is needed." 

The bill passed with unanimous consent out of the Energy and Commerce Committee earlier this year and awaits a vote on the House floor.  

Headline
The AHA July 31 provided comments to the Centers for Medicare & Medicaid Services on its interim final rule on Medicaid community engagement requirements.…
Headline
The Health and Human Services Secretary July 29 announced that dozens of insurers, medical societies, healthcare providers and behavioral health…
Headline
The AHA’s Bridge to Care initiative highlights how hospitals and health systems are strengthening care transitions and supporting ongoing treatment engagement…
Headline
The Centers for Medicare & Medicaid Services today released a proposed rule that would update Medicaid provider tax policies included in the July 2025…
Headline
The AHA provided comments July 21 to the Centers for Medicare & Medicaid Services on its proposed rule to modify policies governing Medicaid…
Headline
The Department of Homeland Security July 16 finalized its proposal to rescind the public charge ground of inadmissibility regulations issued in 2022. Among…